Warfarin Dosing Changes After Bariatric Surgery: Implications on the Mechanism for Altered Dose Requirements and Safety Concerns-An Alternative Viewpoint

Warfarin Users Prone to Coagulopathy in First 30 Days After Hospital Discharge from Gastric Bypass

(2013) Peter Bechtel et al.   OBESITY SURGERY

Assessment of Warfarin Dosing Requirements After Bariatric Surgery in Patients Requiring Long-Term Warfarin Therapy

(2013) Adriane N. Irwin et al.   PHARMACOTHERAPY

Pharmacologic and Mechanical Strategies for Preventing Venous Thromboembolism After Bariatric Surgery

(2013) Daniel J. Brotman et al.   JAMA Surgery

Dietary changes in obese patients undergoing gastric bypass or lifestyle intervention: a clinical trial

(2012) Line K. Johnson et al.   BRITISH JOURNAL OF NUTRITION

Parenteral Anticoagulants

(2012) David A. Garcia et al.   CHEST

Substitution of dalteparin with enoxaparin—a cautionary note

(2010) Conor Magee et al.   Surgery for Obesity and Related Diseases

Anticoagulation: Low-Molecular-Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical Settings

(2009) Edith A Nutescu et al.   ANNALS OF PHARMACOTHERAPY

Bariatric Surgery for the Treatment of Morbid Obesity: A Meta-analysis of Weight Loss Outcomes for Laparoscopic Adjustable Gastric Banding and Laparoscopic Gastric Bypass

(2009) Jane Garb et al.   OBESITY SURGERY

Hemorrhagic and Thromboembolic Complications after Bariatric Surgery in Patients Receiving Chronic Anticoagulation Therapy

(2008) Ramon Mourelo et al.   OBESITY SURGERY

Warfarin Resistance After Total Gastrectomy and Roux-en-Y Esophagojejunostomy

(2008) Diana M Sobieraj et al.   PHARMACOTHERAPY